Case report: Neonatal giant forehead hemangiopericytoma with a 5-year follow-up

3Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Rationale:Hemangiopericytoma (HPC) is a rare pediatric neoplasm with a high risk of bleeding, aggressive growth and high early relapse rates. Surgical excision remains the mainstream treatment, while the functions of chemotherapy and radiotherapy remain controversial. In particular, an infantile giant extracranial HPC located in the forehead has never been reported.Patient concerns:A 3-day-old girl was delivered normally with a giant tumor localized mainly in the right frontal region. The surface of the mass was filled with vascularity.Diagnosis:According to the results of imaging and pathological examinations, the diagnosis was HPC grade II.Interventions:Gross total resection of the tumor and the invading partial frontal bone followed by skin scalp reconstruction was carried out without any blood transfusion.Outcomes:No recurrence was identified during 5 years of follow-up. And better outcomes can be achieved without adjuvant therapy.Lessons:Multimodality imaging and a collaborative multidisciplinary approach are indispensable for the successful surgical management of infantile HPC, especially for giant tumors and their potential risk of life-threatening bleeding. Gross total resection is the optimal option for infantile HPC, and even without adjuvant therapy, it achieves better outcomes.

Cite

CITATION STYLE

APA

Peng, A., Zhang, L., Zhao, H., & Zhou, L. (2019). Case report: Neonatal giant forehead hemangiopericytoma with a 5-year follow-up. Medicine (United States), 98(47). https://doi.org/10.1097/MD.0000000000017888

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free